Texas 2025 89th Regular

Texas House Bill HB4756 Introduced / Bill

Filed 03/13/2025

Download
.pdf .doc .html
                    89R16099 SCR-D
 By: Bell of Montgomery H.B. No. 4756




 A BILL TO BE ENTITLED
 AN ACT
 relating to certain advertisements for prescription drugs.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Subtitle A, Title 16, Business & Commerce Code,
 is amended by adding Chapter 722 to read as follows:
 CHAPTER 722.  CERTAIN ADVERTISEMENTS FOR PRESCRIPTION DRUGS
 Sec. 722.001.  DEFINITION. In this chapter, "paid
 advertisement" means a communication that promotes a good or
 service and is disseminated in exchange for consideration.
 Sec. 722.002.  PROHIBITED ADVERTISEMENT OF CERTAIN
 PRESCRIPTION DRUGS.  (a)  A person may not disseminate a paid
 advertisement for a prescription drug.
 (b)  Subsection (a) does not apply to a paid advertisement
 disseminated:
 (1)  only to medical, dental, or nursing professionals
 in a professional scientific periodical; or
 (2)  only for public health education by a person who is
 not directly or indirectly commercially interested in the sale of
 the drug.
 Sec. 722.003.  DECEPTIVE TRADE PRACTICE. A violation of
 Section 722.002 is a deceptive trade practice in addition to the
 practices described by Subchapter E, Chapter 17, and is actionable
 under that subchapter.
 SECTION 2.  This Act takes effect September 1, 2025.